Searchable abstracts of presentations at key conferences in endocrinology

ea0034p258 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

High serum amylase a contraindication to GLP1 analogue treatment?

Stepien Karolina , Kelly Anne-Marie , Horsman Graham , Younis Naveed

Case: A 41 year-old-Indian woman with type 2 diabetes treated with liraglutide was admitted to the Emergency Department with abdominal pain, nausea, vomiting and bloated abdomen. She was found to have raised amylase at 706 U/l. Abdominal ultrasound and CT scan did not reveal any abnormalities in the pancreas or billary tract and the patient was discharged.She had diabetes for 9 years duration treated with metformin, pioglitazone and liraglutide. Over 2 y...